Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms

被引:2
|
作者
Delluc, Aurelien [1 ,2 ,6 ]
Lacut, Karine [1 ,3 ]
Pan-Petesch, Brigitte [1 ,4 ]
Galinat, Hubert [1 ,4 ]
Lippert, Eric [5 ]
Ianotto, Jean-Christophe [1 ,4 ]
机构
[1] Brest Univ, EA GETBO 3878, F-29200 Brest, France
[2] Hop Cavale Blanche, Dept Chest Dis & Internal Med, F-29609 Brest, France
[3] Hop Cavale Blanche, INSERM CIC 1412, F-29609 Brest, France
[4] Hop Morvan, Oncol & Hematol Inst, F-29609 Brest, France
[5] Brest Univ, IBSAM, Genet Genom Fonct & Biotechnol UMR1078, Lab Hematol,Equipe ECLA, F-29200 Brest, France
[6] Ottawa Hosp, Ottawa Hosp Res Inst, Clin Epidemiol Program, Div Clin Hematol, Box 201B,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
关键词
VENOUS THROMBOEMBOLISM; CANCER; COHORT;
D O I
10.1016/j.thromres.2018.05.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:57 / 59
页数:3
相关论文
共 50 条
  • [21] Splanchnic vein thrombosis (SVT) in patients with myeloproliferative (MPN) neoplasms
    Danaee, A.
    Ahmed, S.
    Patch, D.
    Sekhar, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 65 - 65
  • [22] Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms
    Taniguchi, Yasuhiro
    Tanaka, Hirokazu
    Luis, Espinoza J.
    Sakai, Kazuko
    Kumode, Takahiro
    Sano, Keigo
    Serizawa, Kentarou
    Rai, Shinya
    Morita, Yasuyoshi
    Hanamoto, Hitoshi
    Tsubaki, Kazuo
    Nishio, Kazuto
    Matsumura, Itaru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (05) : 691 - 703
  • [23] Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms
    Yasuhiro Taniguchi
    Hirokazu Tanaka
    Espinoza J. Luis
    Kazuko Sakai
    Takahiro Kumode
    Keigo Sano
    Kentarou Serizawa
    Shinya Rai
    Yasuyoshi Morita
    Hitoshi Hanamoto
    Kazuo Tsubaki
    Kazuto Nishio
    Itaru Matsumura
    International Journal of Hematology, 2017, 106 : 691 - 703
  • [24] Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms A Population-Based Cohort Study
    Hultcrantz, Malin
    Bjorkholm, Magnus
    Dickman, Paul W.
    Landgren, Ola
    Derolf, Asa R.
    Kristinsson, Sigurdur Y.
    Andersson, Therese M. L.
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (05) : 317 - +
  • [25] Risk of thrombosis, hemorrhage and leukemic transformation in patients with myeloproliferative neoplasms: A nationwide longitudinal cohort study
    Hur, Joon Young
    Choi, Nayeon
    Choi, Jung Hye
    Kim, Jiyeong
    Won, Young-Woong
    THROMBOSIS RESEARCH, 2024, 236 : 209 - 219
  • [26] Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms
    Seguro, Fernanda Salles
    Cardoso Teixeira, Larissa Lane
    da Rosa, Lidiane Ines
    da Silva, Wellington Fernandes
    Nardinelli, Luciana
    Bendit, Israel
    Rocha, Vanderson
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (04) : 667 - 672
  • [27] Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms
    Fernanda Salles Seguro
    Larissa Lane Cardoso Teixeira
    Lidiane Inês da Rosa
    Wellington Fernandes da Silva
    Luciana Nardinelli
    Israel Bendit
    Vanderson Rocha
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 667 - 672
  • [28] Molecular biomarkers of thrombosis in myeloproliferative neoplasms
    Barbui, Tiziano
    Falanga, Anna
    THROMBOSIS RESEARCH, 2016, 140 : S71 - S75
  • [29] Splanchnic vein thrombosis in myeloproliferative neoplasms
    Sekhar, Mallika
    McVinnie, Kathryn
    Burroughs, Andrew K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (06) : 730 - 747
  • [30] Thrombosis and platelet dysfunction in myeloproliferative neoplasms
    Mornet, C.
    Galinat, H.
    Mingant, F.
    Ianotto, J. C.
    Lippert, E.
    REVUE DE MEDECINE INTERNE, 2020, 41 (05): : 319 - 324